Corporate News     30-Jun-21
Board of Bal Pharma recommends Final Dividend
Of Rs.1 per share
Bal Pharma announced that the Board of Directors of the Company at its meeting held on 29 June 2021, has recommended a Final dividend of Rs.1 per share (i.e.10%), subject to the approval of the shareholders.
Previous News
  Bal Pharma to convene board meeting
 ( Corporate News - 02-Mar-22   09:55 )
  Bal Pharma to declare Quarterly Result
 ( Corporate News - 28-Jan-23   14:31 )
  Bal Pharma declare Quarterly Result
 ( Corporate News - 30-Apr-24   12:51 )
  Bal Pharma to table results
 ( Corporate News - 21-Jan-21   11:20 )
  Bal Pharma schedules board meeting
 ( Corporate News - 04-Nov-20   18:36 )
  Bal Pharma to table results
 ( Corporate News - 28-Jan-22   17:28 )
  Bal Pharma to declare Quarterly Result
 ( Corporate News - 30-Jul-22   11:45 )
  Bal Pharma standalone net profit declines 51.02% in the June 2015 quarter
 ( Results - Announcements 14-Aug-15   09:06 )
  Bal Pharma standalone net profit declines 89.66% in the December 2018 quarter
 ( Results - Announcements 14-Feb-19   17:40 )
  Bal Pharma reports consolidated net loss of Rs 0.34 crore in the March 2018 quarter
 ( Results - Announcements 31-May-18   15:22 )
  Kaya Ltd leads gainers in 'B' group
 ( Hot Pursuit - 22-Apr-21   12:15 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top